Long-term health consequences of PCOS

Human Reproduction Update

Volumn 8, Issue 3, 2002, Pages 231-241

  Wild, Robert A ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Cardiovascular risk; Diabetes; Endometrial cancer; PCOS

Indexed keywords

ADULT; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; ENDOMETRIUM CANCER; FEMALE; GLUCOSE TOLERANCE TEST; HEREDITY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEDLINE; MORTALITY; OUTCOMES RESEARCH; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UTERUS DISEASE; VASCULAR LESION; INCIDENCE; PATHOLOGY; TIME; UTERUS;

DIABETES MELLITUS; FEMALE; HUMAN; INCIDENCE; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; TIME FACTORS; UTERUS; HUMANS;

EID: 0035984973     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/8.3.231     Document Type: Review

References (59)

1. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
2. Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women
3. Close relation of endothelial function in the human coronary and peripheral circulations
4. Diabetes and endometrial cancer in the Iowa Women's Health Study
5. Body Fat Distribution and Risk for Death in Older Women
6. Increased body mass index predicted mortality in women
7. Review: Glucose levels are associated with cardiovascular risk in persons without diabetes mellitus
8. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance
9. Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden
10. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization
11. Clinical hyperandrogenism and body mass index predict cornary calcification in premenopausal women with polycystic ovary syndrome (PCOS)
12. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus
13. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
14. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of, 95, 783 individuals followed for 12.4 years
15. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
16. Hemostatic and metabolic variables in women with polycystic ovary syndrome
17. [Has oligomenorrhea a pathological meaning? The importance of this symptom in internal medicine]
18. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile
19. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
20. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus
21. Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease
22. Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia?
23. Familial polycystic ovarian disease
24. Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study
25. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: A sign of a pre-hypertensive state?
26. A twin study of polycystic ovary syndrome
27. A twin study of polycystic ovary syndrome and lipids
28. Prevalence of polycystic ovarysyndrome (PCOS) in first-degree relatives of patients with PCOS
29. Risk stratification in hypertension: New insights from the Framingham Study
30. Effect of weight on cardiovascular disease
31. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study
32. The prevalence of polycystic ovaries in women with a history of gestational diabetes
33. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
34. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
35. Insulin resistance
36. Familial clustering in the polycystic ovarian syndrome
37. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome
38. Lipid metabolism in women with polycystic ovary syndrome: Possible implications for an increased risk of coronary heart disease
39. A case-control study of uterine endometrial cancer of pre- and post-menopausal women
40. Hyperinsulinemia is common in family members of women with polycystic ovary syndrome
41. Mortality of women with polycystic ovary syndrome at long-term follow-up
42. Lipids and lipoprotein subfractions in women with PCOS: Relationship to metabolic and endocrine parameters
43. Case-control study of endogenous steroid hormones and endometrial cancer
44. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome
45. A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation
46. Endothelial cell function: New considerations
47. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome
48. Coronary heart disease risk factors in women with polycystic ovary syndrome
49. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: Results of a case-control study
50. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women
51. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
52. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
53. Postprandial triglyceride response in patients with polycystic ovary syndrome: Relationship with waist-to-hip ratio and insulin
54. Polycystic ovary syndrome: A risk for coronary artery disease?
55. The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome
56. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome
57. Clinical signs of androgen excess as risk factors for coronary artery disease
58. Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance
59. Polycystic ovary syndrome: Lack of hypertension despite profound insulin resistance